222. Cognitive Outcomes of the Bumetanide in Autism Medication and Biomarker (BAMBI) Trial

Authors :: Klaus Linkenkaer-Hansen
Jan J. Sprengers
Sonja Simpraga
Hilgo Bruining
Dorinde Marije van Andel
Maretha de Jonge
Erika Juarez-Martinez
Bob Oranje
Source :: Biological Psychiatry. 85:S92
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Cognition
medicine.disease
Internal medicine
medicine
Biomarker (medicine)
Autism
BAMBI
business
Biological Psychiatry
Bumetanide
medicine.drug

Full Text Access

Tools